SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17656594
Source:
http://linkedlifedata.com/resource/pubmed/id/17656594
Search
Subject
(
58
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0085862
,
umls-concept:C0087111
,
umls-concept:C0289313
,
umls-concept:C0442805
,
umls-concept:C1299583
,
umls-concept:C1521761
,
umls-concept:C1549571
,
umls-concept:C1563741
,
umls-concept:C1608386
,
umls-concept:C2587213
pubmed:issue
2
pubmed:dateCreated
2007-7-27
pubmed:abstractText
The goal was to investigate the interrelationships between the hypoglycemic effects of rosiglitazone and the changes in the regional adiposity of type 2 diabetic patients.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9423848
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose
,
http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated
,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Thiazolidinediones
,
http://linkedlifedata.com/resource/pubmed/chemical/rosiglitazone
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0804-4643
pubmed:author
pubmed-author:AhnChul-WooCW
,
pubmed-author:ChaBong-SooBS
,
pubmed-author:ChoYong-WookYW
,
pubmed-author:HurKyu-YeonKY
,
pubmed-author:KimHae-JinHJ
,
pubmed-author:KimSoo-KyungSK
,
pubmed-author:LeeHyun-ChulHC
,
pubmed-author:LimSung-KilSK
,
pubmed-author:ParkSeok-WonSW
,
pubmed-author:ShimWan-SubWS
pubmed:issnType
Print
pubmed:volume
157
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
167-74
pubmed:meshHeading
pubmed-meshheading:17656594-Abdominal Fat
,
pubmed-meshheading:17656594-Blood Glucose
,
pubmed-meshheading:17656594-Body Composition
,
pubmed-meshheading:17656594-Diabetes Mellitus, Type 2
,
pubmed-meshheading:17656594-Female
,
pubmed-meshheading:17656594-Hemoglobin A, Glycosylated
,
pubmed-meshheading:17656594-Humans
,
pubmed-meshheading:17656594-Hypoglycemic Agents
,
pubmed-meshheading:17656594-Lipid Metabolism
,
pubmed-meshheading:17656594-Male
,
pubmed-meshheading:17656594-Middle Aged
,
pubmed-meshheading:17656594-Regression Analysis
,
pubmed-meshheading:17656594-Thiazolidinediones
pubmed:year
2007
pubmed:articleTitle
The increase in abdominal subcutaneous fat depot is an independent factor to determine the glycemic control after rosiglitazone treatment.
pubmed:affiliation
Department of Internal Medicine, College of Medicine, Pochon CHA University, Sungnam, South Korea.
pubmed:publicationType
Journal Article
,
Research Support, Non-U.S. Gov't